China · State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Abuse of a dominant market position
潍坊中源医药有限公司
Why it is here
State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — abuse of a dominant market position (山东省市场监督管理局山东省市场监督管理局 · 市场监管总局发布潍坊中源医药有限公司滥用市场支配地位案行政处罚决定书), from 18 July 2025.
State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — Abuse of a dominant market position.
Details
- Company
- 潍坊中源医药有限公司
- Authority
- State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn)
- Decision
- Abuse of a dominant market position
- Grounds and details, as published
- 山东省市场监督管理局山东省市场监督管理局 · 市场监管总局发布潍坊中源医药有限公司滥用市场支配地位案行政处罚决定书
- From
- 18 July 2025
- Until
- —
- Status
- End date not published
- Source
- https://www.samr.gov.cn/fldys/tzgg/xzcf/art/2025/art_6a5011a047e346688459c3a9817d248d.html
- Licence
- Public antitrust decisions published by the State Administration for Market Regulation of China (samr.gov.cn/fldys)
SourceState Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Abuse of a dominant market position